These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30142699)

  • 1. Design and synthesis of 5-(5-nitrothiophen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazole derivatives with improved solubility and potential antituberculosis activity.
    Khambete M; Kundaikar H; Raju A; Lonkar S; Degani M; Ray MK
    Chem Biol Drug Des; 2019 Jan; 93(1):84-88. PubMed ID: 30142699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
    Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
    Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
    Alegaon SG; Alagawadi KR; Dadwe DH
    Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
    Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
    Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives as potent antitubercular agents.
    Tawari NR; Bairwa R; Ray MK; Rajan MG; Degani MS
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6175-8. PubMed ID: 20850299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains.
    Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Palmer BD; Denny WA; Thompson AM
    J Med Chem; 2010 Jan; 53(2):855-66. PubMed ID: 19968290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
    Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
    J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
    Ali MA; Shaharyar M; Siddiqui AA
    Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
    Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
    Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
    Ali MA; Yar MS; Kumar M; Pandian GS
    Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitubercular activity of novel substituted 4,5-dihydro-1H-1-pyrazolylmethanethiones.
    Ali MA; Yar MS
    J Enzyme Inhib Med Chem; 2007 Apr; 22(2):183-9. PubMed ID: 17518345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
    Karakuş S; Rollas S
    Farmaco; 2002 Jul; 57(7):577-81. PubMed ID: 12164218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives.
    Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S
    Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
    Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.
    Agre N; Khambete M; Maitra A; Gupta A; Munshi T; Bhakta S; Degani M
    Chem Biol Drug Des; 2020 Jan; 95(1):192-199. PubMed ID: 31560814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.